IXC invex therapeutics ltd

Ann: Invex Granted Key European Patent for Exenatide, page-51

  1. 1,507 Posts.
    lightbulb Created with Sketch. 300
    Definitely a good tactic selling half or all after a good phase 2 readout. Bios go into sleeper mode as not much happens for a couple of years and you can make money elsewhere. The tide is definitely turning here, and with low SOI the move will be aggressive.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
9.1¢
Change
0.002(2.25%)
Mkt cap ! $6.839M
Open High Low Value Volume
9.1¢ 9.1¢ 9.1¢ $391 4.299K

Buyers (Bids)

No. Vol. Price($)
1 41290 8.8¢
 

Sellers (Offers)

Price($) Vol. No.
9.7¢ 9000 1
View Market Depth
Last trade - 15.53pm 02/07/2025 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.